Drug intelligence / Profile preview

Alka-5

Development stage
Unknown
Lead developer
Charak
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Alka-5 is an approved proprietary Ayurvedic herbal syrup developed and marketed by Charak Pharma. Formulated as a natural urinary alkalizer, it is designed to maintain normal urine pH balance and support urinary tract health. The product is a multi-ingredient formulation containing key herbal components such as Yavakshara (Hordeum vulgare ash), Shwetparpati, Gokshura (Tribulus terrestris), Dhanyak (Coriandrum sativum), and Jeerak (Cuminum cyminum). It is indicated for the management of dysuria (painful or burning urination), urinary tract infections (UTIs), urethritis, cystitis, sunstroke, and urinary calculi (kidney stones). Alka-5 works by soothing burning urination, reducing inflammation and pain, exhibiting antibacterial activity, and facilitating the flushing of urinary calculi through its diuretic and lithotriptic properties.

Brand names
Alka-5Alka5Alka 5Alka5 SyrupAlka-5 SyrupAlka 5 Syrup
Other names
ALKA5ALKA-5ALKA 5Alka 5 SyrupAlka5 SyrupAlka-5 Syrup

Beyond the preview

Go deeper on Alka-5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alka-5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call